Details for New Drug Application (NDA): 040109
✉ Email this page to a colleague
NDA 040109 describes ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE, which is a drug marketed by Mikart, Wraser Pharms Llc, Boca Pharma Llc, and West-ward Pharm Corp, and is included in five NDAs. Additional details are available on the ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE profile page.
The generic ingredient in ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE is acetaminophen; caffeine; dihydrocodeine bitartrate. There are sixty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the acetaminophen; caffeine; dihydrocodeine bitartrate profile page.
The generic ingredient in ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE is acetaminophen; caffeine; dihydrocodeine bitartrate. There are sixty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the acetaminophen; caffeine; dihydrocodeine bitartrate profile page.
Summary for 040109
| Tradename: | ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE |
| Applicant: | Mikart |
| Ingredient: | acetaminophen; caffeine; dihydrocodeine bitartrate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 356.4MG;30MG;16MG | ||||
| Approval Date: | Aug 26, 1997 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
